Becker's Healthcare September 28, 2022
Genomic testing has been used for years on a case-by-case basis in clinical care, but is now increasingly seen as an important contributor to advancing population health.
During a September Becker’s Hospital Review webinar sponsored by Helix — a population genomics and viral surveillance company — Feby Abraham, PhD, chief strategy officer of Houston-based Memorial Hermann Health System, and James Lu, MD, PhD, co-founder and CEO of Helix, discussed the role of genomics programs in supporting health systems’ population and precision health objectives.
Three key takeaways were:
- Population genomics is an emerging macrotrend that will permeate all parts of healthcare. This outlook is driven by a growing understanding among clinicians of how health determinants — including behavioral, environmental and...